<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-50">
 <label>50</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Penn-Nicholson</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Tameris</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Smit</surname>
    <given-names>E</given-names>
   </name>
   <etal/>
  </person-group>: 
  <article-title>Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial.</article-title>
  <source>
   <italic>Lancet Respir Med.</italic>
  </source>
  <year>2018</year>;
  <volume>6</volume>(
  <issue>4</issue>):
  <fpage>287</fpage>â€“
  <lpage>98</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S2213-2600(18)30077-8</pub-id>
  <?supplied-pmid 29595510?>
  <pub-id pub-id-type="pmid">29595510</pub-id>
 </mixed-citation>
</ref>
